ABBV — AbbVie

Health Care · NYSE/Nasdaq. Last price 286.20 USD (+0.94% on the day). Raven's AI 12-month target: 310.00 USD. Updated 2026-11-20.

Paper-trade AbbVie free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 310.00 USD (+9.33% from 283.54 when it was set on 2026-11-20). Conviction: medium.

Catalysts: ABBV pipeline approvals; M&A optionality

Risks: Patent cliff acceleration; R&D setback

Earnings

Q3 2026 earnings per share: 3.82 USD against 3.76 expected (beat by 1.5%). EPS estimates for 2026: 13.98 USD (29 analysts), 2027: 16.22 USD (29 analysts). The 2026 estimate has moved -0.2% over 90 days.

Dividends

AbbVie has paid 6.92 USD per share in dividends over the last 12 months (2.4% yield). Last dividend: 1.73 USD per share, ex-dividend 2026-10-15. Next ex-dividend date: 2027-01-15.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical · JNJ Johnson & Johnson

RAVEN is taking longer than usual to load.
RELOAD